NCT07547813
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +8 more
- Locations
-
- Alm Site 1 Warsaw, Masovian Voivodeship, Poland
Clinical trial condition
Hidradenitis
Explore clinical trials studying Hidradenitis. Study availability and eligibility vary by location and protocol.
25 public trials
5 recruiting studies
Hidradenitis trial results
NCT06855498
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
- Locations
-
- Investigative Site US106 Birmingham, Alabama, United States
- Investigative Site US086 Birmingham, Alabama, United States
- Investigative Site US098 Montgomery, Alabama, United States
- Investigative Site US004 Phoenix, Arizona, United States
NCT07213973
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
- Locations
-
- University of Alabama At Birmingham Birmingham, Alabama, United States
- Medical Dermatology Specialists Phoenix Phoenix, Arizona, United States
- Saguaro Dermatology Phoenix, Arizona, United States
- Uconn Health Farmington, Connecticut, United States
Recruiting
SAR447971 First-in-human Study
NCT07629336
- Conditions
- Healthy Volunteers, Hidradenitis, Skin Diseases, +2 more
- Locations
-
- Investigational Site Number: 5280001 Leiden, Netherlands
NCT04218422
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +12 more
- Locations
-
- WSUPG Dermatology Dearborn, Michigan, United States
Not yet recruiting
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
NCT07766005
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +9 more
- Locations
-
- Site 111 Irvine, California, United States
- Site 101 Indianapolis, Indiana, United States
- Site 100 Bowling Green, Kentucky, United States
- Site 108 Baton Rouge, Louisiana, United States
Enrolling by invitation
A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07007637
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Hidradenitis, +11 more
- Locations
-
- Clinical Site Birmingham, Alabama, United States
- Clinical Site North Little Rock, Arkansas, United States
- Clinical Site Los Angeles, California, United States
- Clinical Site Northridge, California, United States
Active, not recruiting
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
NCT06840392
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
- Locations
-
- Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States
- CTT Research Gilbert, Arizona, United States
- Ctr for Dermatology Clinical Res Fremont, California, United States
- USC Keck School of Medicine Los Angeles, California, United States
Active, not recruiting
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
NCT06799000
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Dermatitis, +9 more
- Locations
-
- Medical Dermatology Specialists Phoenix, Arizona, United States
- Johnson Dermatology Fort Smith, Arkansas, United States
- Arkansas Research Trials North Little Rock, Arkansas, United States
- Cheryl Effron MD Inc Anaheim, California, United States
Active, not recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
NCT06993610
- Conditions
- Acne Vulgaris, Acneiform Eruptions, Bacterial Infections, +13 more
- Locations
-
- Medical Dermatology Specialists (Phoenix) Phoenix, Arizona, United States
- First OC Dermatology Research, Inc. Irvine, California, United States
- Wallace Medical Group, Inc. Los Angeles, California, United States
- Northridge Clinical Trials Northridge, California, United States